Roberto Maj
Directeur des opérations chez Kupando GmbH
Profil
Roberto Maj is the founder of Telormedix SA, which was founded in 2007.
He held the title of Head-Product Development from 2010 to 2013.
Currently, he is the Head-Operations at Kupando GmbH.
Dr. Maj's former positions include Senior Researcher-CNS Department at Pharmacia & Upjohn, Inc., Head-Drug Development at THERAMetrics holding AG, Head-Preclinical Development at Newron Pharmaceuticals SpA, and Head-Drug Development at Brane Discovery SRL.
Dr. Maj received his undergraduate and graduate degrees from the University of Warsaw.
Postes actifs de Roberto Maj
| Sociétés | Poste | Début |
|---|---|---|
Kupando GmbH
 Kupando GmbH BiotechnologyHealth Technology Kupando GmbH is a German biopharmaceutical company that develops agonists to stimulate innate immunity. The company is based in Schoenefeld, Germany. The company was founded in 2018 by Johanna Holldack, who has been the CEO since 2018. | Directeur des opérations | - |
Anciens postes connus de Roberto Maj
| Sociétés | Poste | Fin |
|---|---|---|
| Brane Discovery SRL | Corporate Officer/Principal | - |
THERAMetrics holding AG
 THERAMetrics holding AG Pharmaceuticals: MajorHealth Technology THERAMetrics holding AG is an independent biotech company, which discovers drugs for patients suffering from rare diseases. The company was founded by Fabio Cavalli, Vera Cavalli, Patrick Pozzorini, Dorian Bevec and Michael von und zu Liechtenstein on February 9, 2001 and is headquartered in Stans, Switzerland. | Corporate Officer/Principal | - |
| NEWRON PHARMACEUTICALS S.P.A. | Corporate Officer/Principal | - |
| Pharmacia & Upjohn, Inc. | Corporate Officer/Principal | - |
Telormedix SA
 Telormedix SA Pharmaceuticals: MajorHealth Technology Telormedix SA operates as a biopharmaceutical company, that focuses on targeted immunity in the treatment of cancer and other diseases. Its products include TMX-101 for the treatment of localized bladder cancer, TMX-201 for the topical treatment of bladder cancer, skin cancer, and other indications, as well as for use as a vaccine adjuvant, and TMX-302 for use in preclinical trials for the treatment of autoimmune disease. The company was founded in October 2007 by Lorenzo Leoni, Roberto Maj, Rolf M. Zinkernagel and Dennis A. Carson and is headquartered in Lugano, Switzerland. | Fondateur | - |
Formation de Roberto Maj
| University of Warsaw | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| NEWRON PHARMACEUTICALS S.P.A. | Health Technology |
| Entreprise privées | 5 |
|---|---|
| Pharmacia & Upjohn, Inc. | Health Technology |
THERAMetrics holding AG
THERAMetrics holding AG Pharmaceuticals: MajorHealth Technology THERAMetrics holding AG is an independent biotech company, which discovers drugs for patients suffering from rare diseases. The company was founded by Fabio Cavalli, Vera Cavalli, Patrick Pozzorini, Dorian Bevec and Michael von und zu Liechtenstein on February 9, 2001 and is headquartered in Stans, Switzerland. | Health Technology |
Telormedix SA
Telormedix SA Pharmaceuticals: MajorHealth Technology Telormedix SA operates as a biopharmaceutical company, that focuses on targeted immunity in the treatment of cancer and other diseases. Its products include TMX-101 for the treatment of localized bladder cancer, TMX-201 for the topical treatment of bladder cancer, skin cancer, and other indications, as well as for use as a vaccine adjuvant, and TMX-302 for use in preclinical trials for the treatment of autoimmune disease. The company was founded in October 2007 by Lorenzo Leoni, Roberto Maj, Rolf M. Zinkernagel and Dennis A. Carson and is headquartered in Lugano, Switzerland. | Health Technology |
| Brane Discovery SRL | |
Kupando GmbH
Kupando GmbH BiotechnologyHealth Technology Kupando GmbH is a German biopharmaceutical company that develops agonists to stimulate innate immunity. The company is based in Schoenefeld, Germany. The company was founded in 2018 by Johanna Holldack, who has been the CEO since 2018. | Health Technology |
